Twitter a Popular Source for Vaccination Information, Debate
Washington, DC, May 30, 2013 /3BL Media/ – Twitter is a popular source for receiving and sharing new information about vaccines, and also a basically reliable one, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
Researchers from the University of Texas at Austin analyzed 9,510 vaccination-related tweets from one week in January, 2012 to determine the most popular and influential messages. A final sample of 2,580 tweets that had received engagement through re-posting and sharing was then coded for frequency of sharing, tone toward vaccinations, links to sources (e.g., news outlets, advocacy groups, or healthcare providers), and whether the claims being made in each tweet were scientifically substantiated.
Overall, 33 percent of the 2,580 tweets carried a positive tone about vaccines, 54 percent were neutral, and 13 percent were negative. Of the 14 percent of tweets that contained medical information, more than two-thirds offered content substantiated by scientific research.
The most popular messages concerned a potential children’s malaria vaccine, development of the NeuVax E-75 vaccine for breast cancer, the effectiveness of a herpes vaccine in women, the Centers for Disease Control and Prevention’s recommendation of a human papilloma virus vaccination for boys, potential approval for a lung cancer vaccine, and a blog post discrediting vaccine-autism connections.
Frequent information sources shared through tweets included health-specific sites such as WebMD (16 percent of 341 links), national media such as The New York Times (13 percent), medical organizations such as the American Medical Association (12 percent), and digital news aggregators including the Huffington Post (10 percent). The specific outlets mentioned are representative examples, though did dominate their categories.
“News and health organizations received mostly positive attention in comparison with political or advocacy groups, indicating users are favorably viewing established sources in their health-information seeking,” state the authors. “In this sample, it appears that Twitter users share mostly reputable information and sources while actively mobilizing others to seek reliable health information. Results of the snapshot can help explain what social media content patients consume and respond to, as well as help determine directions for educational campaigns.”
Notes for Editors
“Twitter as a source of vaccination information: Content drivers and what they are saying” by Brad Love, Itai Himelboim, Avery Holton, and Kristin Stewart appears in the American Journal of Infection Control, Volume 41, Issue 6 (June 2013).
Authors:
Brad Love, PhD (Corresponding Author)
University of Texas at Austin, Austin, TX
Itai Himelboim, PhD
University of Georgia, Athens, GA
Avery Holton, MA
University of Texas at Austin, Austin, TX
Kristin Stewart, MBA
University of Texas at Austin, Austin, TX
About AJIC: American Journal of Infection Control
AJIC: American Journal of Infection Control (www.ajicjournal.org) covers key topics and issues in infection control and epidemiology. Infection preventionists, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of APIC, AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. Published by Elsevier, AJIC is included in MEDLINE and CINAHL.
About APIC
APIC’s mission is to create a safer world through prevention of infection. The association’s more than 14,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities. APIC advances its mission through patient safety, implementation science, competencies and certification, advocacy, and data standardization. Visit APIC online at www.apic.org. Follow APIC on Twitter: http://twitter.com/apic.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Media contact
Liz Garman
+1 202 454 2604
egarman@apic.org
